E80.0 Hereditary erythropoietic porphyria

Name of the Condition

• Hereditary Erythropoietic Porphyria

Summary

Hereditary erythropoietic porphyria is a rare genetic disorder characterized by defects in heme synthesis, leading to the accumulation of porphyrins in the body. This condition primarily affects the skin and can cause photosensitivity, blistering, and other dermatological symptoms. It is inherited in an autosomal recessive pattern and typically presents in early childhood.

Causes

The disorder is caused by mutations in the uroporphyrinogen III synthase (UROS) gene, which disrupts the final step of heme production. This results in the buildup of uroporphyrinogen I and III, leading to the clinical manifestations of the condition. The genetic mutation is inherited from both parents, who are usually asymptomatic carriers.

Risk Factors

• Genetic inheritance of UROS gene mutations from both parents.
• Family history of hereditary erythropoietic porphyria or related porphyrias.
• Exposure to sunlight or ultraviolet (UV) radiation, which exacerbates symptoms.

Symptoms

• Severe photosensitivity, with skin reactions occurring shortly after sun exposure.
• Blistering, scarring, and hypertrichosis (excessive hair growth) on sun-exposed areas.
• Reddish-brown urine, which may darken upon standing.
• Anemia and splenomegaly (enlarged spleen) in some cases.
• Dental discoloration (reddish-brown teeth) due to porphyrin deposition.

Diagnosis

Diagnosis is confirmed through laboratory tests, including elevated levels of uroporphyrin in urine and erythrocytes. Genetic testing for UROS gene mutations may be performed to confirm the diagnosis. A thorough clinical evaluation, including family history and physical examination, is essential for accurate identification.

Treatment Options

Treatment focuses on avoiding sun exposure and using protective measures, such as sunscreen and clothing. Hematopoietic stem cell transplantation may be considered in severe cases. Supportive care, including managing skin lesions and anemia, is also part of the management plan.

Prognosis and Follow-Up

The prognosis varies depending on the severity of symptoms and response to treatment. Regular follow-up with a healthcare provider is necessary to monitor for complications, such as skin damage or organ involvement. Early intervention can help manage symptoms and improve quality of life.

Complications

• Chronic skin damage, including scarring and disfigurement.
• Increased risk of skin infections due to open lesions.
• Potential for hemolytic anemia, leading to fatigue and weakness.
• Psychological impact from visible skin changes and social stigma.

Lifestyle & Prevention

• Strict avoidance of sunlight and UV exposure, including using broad-spectrum sunscreen and protective clothing.
• Regular monitoring of skin health and prompt treatment of lesions.
• Genetic counseling for families to understand inheritance risks and options.

When to Seek Professional Help

Seek medical attention if you experience severe photosensitivity, unexplained skin blistering, or changes in urine color. Early evaluation is crucial for diagnosis and management to prevent long-term complications.

Tips for Medical Coders

When coding for hereditary erythropoietic porphyria, use the ICD-10-CM code E80.0. Ensure documentation includes confirmation of genetic testing or laboratory results showing elevated porphyrin levels, as well as details of clinical presentation (e.g., photosensitivity, skin lesions). Accurate coding requires specificity about the condition and its manifestations to support appropriate reimbursement and clinical tracking.